Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
T-Mobile US
TMUS
|
+$576M |
| 2 |
AbbVie
ABBV
|
+$478M |
| 3 |
Snap
SNAP
|
+$318M |
| 4 |
Boston Scientific
BSX
|
+$284M |
| 5 |
Lam Research
LRCX
|
+$260M |
Top Sells
| 1 |
Boeing
BA
|
+$389M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$309M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$284M |
| 4 |
Shopify
SHOP
|
+$240M |
| 5 |
Sysco
SYY
|
+$217M |
Sector Composition
| 1 | Technology | 30.65% |
| 2 | Healthcare | 19.7% |
| 3 | Consumer Discretionary | 10.82% |
| 4 | Financials | 9.88% |
| 5 | Communication Services | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Innoviva
INVA
$1.27B
| $1.67M | ﹤0.01% |
119,716
+57,648
| +93% | +$806K |
|
1052
NOV
NOV
$4.85B
| $1.67M | ﹤0.01% |
136,106
-1,798
| -1% | -$22K |
|
1053
ACM Research
ACMR
$1.79B
| $1.65M | ﹤0.01% |
79,437
+43,893
| +123% | +$912K |
|
1054
Corcept Therapeutics
CORT
$7.56B
| $1.65M | ﹤0.01% |
98,095
+78,205
| +393% | +$1.31M |
|
1055
John Wiley & Sons Class A
WLY
$2.23B
| $1.64M | ﹤0.01% |
42,056
-9,330
| -18% | -$364K |
|
1056
Mohawk Industries
MHK
$8.42B
| $1.6M | ﹤0.01% |
15,710
-12,201
| -44% | -$1.24M |
|
1057
PTC
PTC
$24.4B
| $1.59M | ﹤0.01% |
20,432
-394
| -2% | -$30.6K |
|
1058
Vanguard Total International Bond ETF
BNDX
$68.4B
| $1.58M | ﹤0.01% |
27,376
-10,400
| -28% | -$600K |
|
|
STSA
1059
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $1.57M | ﹤0.01% |
54,633
-9,743
| -15% | -$280K |
|
|
BSX.PRA
1060
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
| $1.57M | ﹤0.01% |
+14,971
| New | +$1.57M |
|
1061
LKQ Corp
LKQ
$8.31B
| $1.56M | ﹤0.01% |
59,634
-7,577
| -11% | -$198K |
|
1062
Federal Realty Investment Trust
FRT
$8.66B
| $1.56M | ﹤0.01% |
18,295
-56,102
| -75% | -$4.78M |
|
1063
Rocket Pharmaceuticals
RCKT
$346M
| $1.54M | ﹤0.01% |
73,569
+5,579
| +8% | +$117K |
|
1064
Diamondback Energy
FANG
$39.5B
| $1.53M | ﹤0.01% |
36,630
+771
| +2% | +$32.3K |
|
1065
Insight Enterprises
NSIT
$3.99B
| $1.52M | ﹤0.01% |
30,885
+11,448
| +59% | +$563K |
|
1066
Lear
LEA
$5.91B
| $1.51M | ﹤0.01% |
13,886
-2,119
| -13% | -$231K |
|
1067
iShares 20+ Year Treasury Bond ETF
TLT
$49.2B
| $1.51M | ﹤0.01% |
9,218
-3,031
| -25% | -$497K |
|
1068
Robert Half
RHI
$3.65B
| $1.51M | ﹤0.01% |
28,538
+134
| +0.5% | +$7.08K |
|
1069
Copa Holdings
CPA
$4.69B
| $1.48M | ﹤0.01% |
29,284
-3,978
| -12% | -$201K |
|
1070
Nektar Therapeutics
NKTR
$924M
| $1.48M | ﹤0.01% |
4,246
-288
| -6% | -$100K |
|
1071
Napco Security Technologies
NSSC
$1.43B
| $1.47M | ﹤0.01% |
125,974
+99,162
| +370% | +$1.16M |
|
|
SEI
1072
Solaris Energy Infrastructure, Inc.
SEI
$1.11B
| $1.46M | ﹤0.01% |
197,283
-663,876
| -77% | -$4.93M |
|
1073
Supernus Pharmaceuticals
SUPN
$2.58B
| $1.46M | ﹤0.01% |
61,615
+29,473
| +92% | +$700K |
|
1074
CACI
CACI
$10.5B
| $1.46M | ﹤0.01% |
6,740
-6,185
| -48% | -$1.34M |
|
1075
Kearny Financial
KRNY
$413M
| $1.4M | ﹤0.01% |
170,940
+7,216
| +4% | +$59K |
|